Fuente: Fortune
Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.
Leer en la Fuente
Noticias Relacionadas
Lista de Noticias
Fuente: Fortune
Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.